|
Nephrology Hypertension Journal Club: A spatially anchored transcriptomic atlas of the human kidney papilla identifies significant immune injury in patients with stone disease (October 6, 2023) |
10/06/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: Severe Hyponatremia Correction, Mortality, and Central Pontine Myelinolysis (October 13, 2023) |
10/13/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant receipts: Phase 3 IMAGINE study rationale and design (October 27, 2023) |
10/27/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: Aldosterone Synthase Inhibition With Lorundrostate for Uncontrolled Hypertension The Target-HTN Randomized Clinical Trial (November 10, 2023) |
11/10/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: Podocyte Injury at Young Age Causes Premature Senescence and Worsens Glomerular Aging (November 17, 2023) |
11/17/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy (December 1, 2023) |
12/01/2023 - 7:30am to 8:30am |
|
Nephrology Hypertension Journal Club: Treatment Effect of the SGLT2 Inhibitor Empagliflozin on Chronic Syndrome of Inappropriate Antidiuresis: Results of a Randomized, Double-Blind, Placebo-Controlled, Crossover Trial (December 15, 2023) |
12/15/2023 - 7:30am to 8:30am |
Facebook
Twitter
LinkedIn
Forward